Katerina Papageorgiou
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Katerina Papageorgiou has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
- Adelita V. Ranchor
Department of Health Sciences, Section of Health Psychology, University of Groningen, University Medical Center Groningen , 9713 GZ Groningen
2 shared publications - Erik Buskens
Epidemiology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands
2 shared publications - Anne Margarethe Stiggelbout
Department of Biomedical Data Sciences, Leiden University Medical Center, Leiden, the Netherlands
1 shared publication Edwin van Den Heuvel
Department of Epidemiology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands
1 shared publicationKarin M. Vermeulen
Department of Epidemiology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands
1 shared publication- Karin M. Vermeulen
Department of Epidemiology University Medical Center Groningen, University of Groningen Groningen The Netherlands
1 shared publication
Latest Publications
- Open Access
- 3 June 2015
- Published by Springer Nature in Quality of Life Research
- Vol. 24 (11) , 2565-2575
Do individuals with and without depression value depression differently? And if so, why?
Health state valuations, used to evaluate the effectiveness of healthcare interventions, can be obtained either by the patients or by the general population. The general population seems to value somatic conditions more negatively than patients, but little is known about valuations of psychological conditions. This study examined whether individuals with and without depression differ in their valuations of depression and whether perceptions regarding depression (empathy, perceived susceptibility, stigma, illness perceptions) and individual characteristics (mastery, self-compassion, dysfunctional attitudes) bias valuations of either individuals with or without depression.
- 3 June 2015
- Published by Springer Nature in Quality of Life Research
- Vol. 24 (11) , 2565-2575
Open AccessDo individuals with and without depression value depression differently? And if so, why?
Health state valuations, used to evaluate the effectiveness of healthcare interventions, can be obtained either by the patients or by the general population. The general population seems to value somatic conditions more negatively than patients, but little is known about valuations of psychological conditions. This study examined whether individuals with and without depression differ in their valuations of depression and whether perceptions regarding depression (empathy, perceived susceptibility, stigma, illness perceptions) and individual characteristics (mastery, self-compassion, dysfunctional attitudes) bias valuations of either individuals with or without depression.
- Open Access
- 1 January 2013
- Published by Springer Nature in Health and Quality of Life Outcomes
- Vol. 11 (1) , 125
Testing the McSad depression specific classification system in patients with somatic conditions: validity and performance
Valuations of depression are useful to evaluate depression interventions offered to patients with chronic somatic conditions. The only classification system to describe depression developed specifically for valuation purposes is the McSad, but it has not been used among somatic patients. The aim of this study was to test the construct validity of the McSad among diabetes and cancer patients and then to compare the McSad to the commonly used EuroQol – 5 Dimensions (EQ-5DTM) classification system. The comparison was expected to shed light on their capacity to reflect the range of depression states experienced by somatic patients.
- 1 January 2013
- Published by Springer Nature in Health and Quality of Life Outcomes
- Vol. 11 (1) , 125
Open AccessTesting the McSad depression specific classification system in patients with somatic conditions: validity and performance
Valuations of depression are useful to evaluate depression interventions offered to patients with chronic somatic conditions. The only classification system to describe depression developed specifically for valuation purposes is the McSad, but it has not been used among somatic patients. The aim of this study was to test the construct validity of the McSad among diabetes and cancer patients and then to compare the McSad to the commonly used EuroQol – 5 Dimensions (EQ-5DTM) classification system. The comparison was expected to shed light on their capacity to reflect the range of depression states experienced by somatic patients.